Paper29080554
LOXL2 as a protective in osteoarthritis cartilage.
Bais MV and 1 other. Aging (Albany NY), 2017. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. LOXL2 as a protective in osteoarthritis cartilage. Papers, record 29080554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29080554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acid Oxidoreductases | Major topic |
| Cartilage | Major topic |
| Osteoarthritis | Major topic |
| Aging | |
| Gene Expression Regulation, Enzymologic | |
| Genetic Predisposition to Disease | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R03 DE025274 | NIDCR NIH HHS | United States | R03DE025274 | PubMed and NIH | NIH RePORTER |
| R21 DE026892 | NIDCR NIH HHS | United States | R21DE026892 | PubMed | NIH RePORTER |
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28764769 | Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis. | Arthritis Res Ther | 2017 | https://conductscience.org/library/papers/28764769 | PubMed |
| 2 | 16947423 | Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/16947423 | PubMed |
| 3 | 13130470 | Osteoarthritis-like changes and decreased mechanical function of articular cartilage in the joints of mice with the chondrodysplasia gene (cho). | Arthritis Rheum | 2003 | https://conductscience.org/library/papers/13130470 | PubMed |
| 4 | 19415118 | Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. | PLoS One | 2009 | https://conductscience.org/library/papers/19415118 | PubMed |
| 5 | 21071451 | Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21071451 | PubMed |
| 6 | 29088714 | Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29088714 | PubMed |
| 7 | 25959397 | LOXL2 Oxidizes Methylated TAF10 and Controls TFIID-Dependent Genes during Neural Progenitor Differentiation. | Mol Cell | 2015 | https://conductscience.org/library/papers/25959397 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32621591 | LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32621591 | PubMed |
| 32426343 | Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32426343 | PubMed |
| 32323822 | LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32323822 | PubMed |
| 31569601 | Lysyl Oxidase-Like 2 Protects against Progressive and Aging Related Knee Joint Osteoarthritis in Mice. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31569601 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACAN | 176 | PubTator's text mining | https://conductscience.org/library/genes/176 | NCBI Gene |
| COL2A1 | 1280 | PubTator's text mining | https://conductscience.org/library/genes/1280 | NCBI Gene |
| CSPG4 | 1464 | PubTator's text mining | https://conductscience.org/library/genes/1464 | NCBI Gene |
| LOXL2 | 4017 | PubTator's text mining | https://conductscience.org/library/genes/4017 | NCBI Gene |
| MMP13 | 4322 | PubTator's text mining | https://conductscience.org/library/genes/4322 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PRG4 | 10216 | PubTator's text mining | https://conductscience.org/library/genes/10216 | NCBI Gene |
| SOX9 | 6662 | PubTator's text mining | https://conductscience.org/library/genes/6662 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29080554
GET https://conductscience.org/api/papers/v1/29080554/authors